melanoma

ASCO ® Plenary Series
March 14, 2022 · Brielle Gregory Collins, ASCO staff
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer. Read More >>
ASCO ® Plenary Series
November 15, 2021 · Greg Guthrie, ASCO staff
Research from the first ASCO Plenary Series presentation has arrived. Read more about studies on using immunotherapy to treat metastatic melanoma and how technology can be used to find and manage symptoms during cancer treatment. Read More >>
August 16, 2021 · Brielle Gregory Collins, ASCO staff
In this webinar, experts discuss new research in gynecologic cancers, advanced melanoma, and cancer in people age 65 or older presented at the 2021 ASCO Annual Meeting. Read More >>
2021 ASCO Annual Meeting; #ASCO21
May 19, 2021 · ASCO Staff
Read early research highlights just released for the 2021 ASCO Annual Meeting. Topics include immunotherapy for melanoma and non-small cell lung cancer, PSA screening for prostate cancer, HPV vaccination, and Medicaid income eligibility limits. Read More >>
2021 ASCO Annual Meeting; #ASCO21
May 19, 2021 · ASCO Staff
Lea los puntos destacados de la investigación temprana que acaban de publicar para la reunión anual de la American Society of Clinical Oncology (Sociedad Americana de Oncología Clínica) de 2021. Los temas incluyen la inmunoterapia para el melanoma y el cáncer de pulmón de no microcítico (NSCLC, por sus siglas en inglés), la detección del antígeno prostático específico (PSA, por sus siglas en inglés) para el cáncer de próstata, la vacunación contra el VPH y los límites de elegibilidad de los ingresos de Medicaid. Read More >>

Pages